Scarica l'app Stockscreener
1.56
0.64%
-0.01
Dopo l'orario di chiusura:
1.60
0.04
+2.56%
Precedente Chiudi:
$1.57
Aprire:
$1.58
Volume 24 ore:
216.24K
Relative Volume:
0.68
Capitalizzazione di mercato:
$34.88M
Reddito:
-
Utile/perdita netta:
$-16.51M
Rapporto P/E:
-1.1532
EPS:
-1.3528
Flusso di cassa netto:
$-15.68M
1 W Prestazione:
+1.96%
1M Prestazione:
-23.53%
6M Prestazione:
-47.83%
1 anno Prestazione:
-46.94%
Intervallo 1D:
$1.50
$1.65
Intervallo di 1 settimana:
$1.50
$1.70
Portata 52W:
$1.45
$8.94
Medicus Pharma Ltd Stock (MDCX) Company Profile
Nome
Medicus Pharma Ltd
Settore
Industria
Telefono
610-540-7515
Indirizzo
300 CONSHOHOCKEN STATE RD., W. CONSHOHOCKEN
Confronta MDCX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MDCX
Medicus Pharma Ltd
|
1.56 | 35.11M | 0 | -16.51M | -15.68M | -1.3528 |
|
LLY
Lilly Eli Co
|
1,085.19 | 991.76B | 59.42B | 18.41B | 6.44B | 20.22 |
|
JNJ
Johnson Johnson
|
205.75 | 499.90B | 92.15B | 25.12B | 20.46B | 10.36 |
|
ABBV
Abbvie Inc
|
224.13 | 412.54B | 59.64B | 2.36B | 19.68B | 1.3253 |
|
MRK
Merck Co Inc
|
110.99 | 269.55B | 63.90B | 19.05B | 13.05B | 7.5596 |
|
NVS
Novartis Ag Adr
|
141.46 | 272.43B | 54.45B | 14.42B | 17.15B | 7.333 |
Medicus Pharma Ltd Borsa (MDCX) Ultime notizie
Why Medicus Pharma Ltd. stock could rally in 2025GDP Growth & Short-Term High Return Strategies - ulpravda.ru
MACD Signal: Is Medicus Pharma Ltd. stock overvalued by current metricsJuly 2025 Trends & Daily Stock Trend Reports - ulpravda.ru
Is Medicus Pharma Ltd. stock overvalued by current metricsMarket Sentiment Report & Smart Investment Allocation Insights - ulpravda.ru
Why Medicus Pharma Ltd. Equity Warrant stock is popular among millennialsQuarterly Trade Review & Trade Opportunity Analysis Reports - ulpravda.ru
Will Medicus Pharma Ltd. Equity Warrant stock pay special dividends2025 Pullback Review & Growth Focused Stock Pick Reports - ulpravda.ru
Why Medicus Pharma Ltd. (N460) stock stays undervaluedPortfolio Performance Report & Safe Investment Capital Preservation Plans - ulpravda.ru
Why retail investors pile into Medicus Pharma Ltd. Equity Warrant stockBear Alert & Accurate Entry/Exit Alerts - ulpravda.ru
Can Medicus Pharma Ltd. stock double in next 5 years2025 Analyst Calls & Verified Trade Idea Suggestions - ulpravda.ru
Is Medicus Pharma Ltd. Equity Warrant stock positioned for long term growthJuly 2025 Setups & Fast Momentum Entry Tips - ulpravda.ru
What insider trading reveals about Medicus Pharma Ltd. stock2025 Sector Review & Reliable Price Breakout Signals - ulpravda.ru
Will Medicus Pharma Ltd. Equity Warrant stock see PE expansionRate Cut & Weekly Stock Breakout Alerts - ulpravda.ru
Medicus Pharma Ltd. Announces Engagement With Reliant AI to Develop Artificial Intelligence (AI) Driven Clinical Data Analytics Platform - The Providence Journal
Medicus Pharma enters non-binding LOI with Reliant AI - MSN
Will Medicus Pharma Ltd. stock deliver better than expected guidanceGeopolitical Risk Analysis & Turn Data into Profits With Our Strategies - ulpravda.ru
How supply chain issues affect Medicus Pharma Ltd. stockRelative Strength Index (RSI) & Learn What Analysts Rate “Strong Buy” - ulpravda.ru
Why Medicus Pharma Ltd. stock could see breakout soonResistance Zone Identification & Small Budget Investment Tips - ulpravda.ru
2026 world cup world class players analysis: Will Medicus Pharma Ltd. Equity Warrant stock benefit from green energy trends2026 world cup usa national team quarterfinals key players low block defense expert forecast expert opinion - ulpravda.ru
Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement - Central New Jersey News
Medicus Pharma ramps up partnering push as Phase 2 SkinJect data nears - MSN
Medicus Pharma Ltd. to Present at The Maxim Growth Summit 2025FDL Reporter | The Reporter - fdlreporter.com
Medicus Pharma to present phase 2 data at Biotech Showcase 2026 - Investing.com Nigeria
2026 world cup analysis guide: Why Medicus Pharma Ltd. stock could benefit from AI revolution2026 world cup usa national team group stage top scorers transition play tactical prediction guide - ulpravda.ru
Medicus Pharma to highlight multiple Phase 2 catalysts at Biotech Showcase 2026 - Proactive financial news
Medicus Pharma Ramps Up Partnering Push as Phase 2 SkinJect Data Nears - TipRanks
Medicus Pharma Ltd. to Present at Biotech Showcase 2026 as SkinJect Phase 2 Clinical Data Approaches Readout and Partnering Readiness Accelerates - The Manila Times
Medicus Pharma Ltd. to Present at Biotech Showcase 2026 as - GlobeNewswire
Setup Watch: Can Medicus Pharma Ltd stock double in next 5 yearsWeekly Earnings Recap & Reliable Momentum Entry Alerts - moha.gov.vn
Medicus Pharma Ltd. Provides Corporate Updates and Reports Third Quarter 2025 Financial Highlights - Victorville Daily Press
Medicus Pharma Ltd. Announces Collaboration with the Gorlin Syndrome Alliance to Pursue Compassionate Use Pathway for Skinject(TM) in Patients with Gorlin Syndrome - The Coloradoan
Dated alerts on Medicus Pharma withdrawn - marketscreener.com
What drives Medicus Pharma Ltd stock priceResistance Breakout Alerts & Test Our Stock Screener — Free Forever - earlytimes.in
Medicus Pharma enters equity distribution agreement for up to $15.3 million By Investing.com - Investing.com Australia
Medicus Pharma enters equity distribution agreement for up to $15.3 million - Investing.com Nigeria
Medicus Pharma Launches At-the-Market Equity Offering Program - TipRanks
Medicus Pharma Signs Equity Distribution Agreement With Maxim Group and Yorkville Securities - TradingView — Track All Markets
Medicus Pharma to offer securities worth up to $100 millionSEC filing - MarketScreener
Medicus Pharma launches at-the-market equity offering program - MSN
Medicus Pharma Ltd. Announces First Patient Treated in United Arab Emirates (UAE) Sknjct-004 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin - Lubbock Avalanche-Journal
Medicus Pharma Ltd Azioni (MDCX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.50%
0.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):